Synergy Pharmaceuticals Inc. today announced positive top-line results from a phase 2b dose-ranging study assessing plecanatide's safety and efficacy in 424 patients with irritable bowel syndrome with constipation .
http://ift.tt/S9BzRw
http://ift.tt/S9BzRw
No comments:
Post a Comment